ConductScience.org, home

Gene · 7150

Trials2,417

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

121 to 140 of 2,417

Download this page as JSON
TrialDrugPhaseResults first postedSource
NCT07152782TRASTUZUMAB DERUXTECANPHASE2ClinicalTrials.gov
NCT07151586SACITUZUMAB GOVITECANPHASE2ClinicalTrials.gov
NCT07151586TRASTUZUMAB DERUXTECANPHASE2ClinicalTrials.gov
NCT07150403IRINOTECANPHASE2ClinicalTrials.gov
NCT07150247IRINOTECANPHASE2ClinicalTrials.gov
NCT07150208TRASTUZUMAB DERUXTECANPHASE2ClinicalTrials.gov
NCT07145333TOPOTECANPHASE2/PHASE3ClinicalTrials.gov
NCT07137416TRASTUZUMAB DERUXTECANPHASE1ClinicalTrials.gov
NCT07134556SACITUZUMAB GOVITECANPHASE2ClinicalTrials.gov
NCT07134205IRINOTECANPHASE3ClinicalTrials.gov
NCT07134153TRASTUZUMAB DERUXTECANPHASE1/PHASE2ClinicalTrials.gov
NCT07129993DATOPOTAMAB DERUXTECANPHASE2/PHASE3ClinicalTrials.gov
NCT07126561TRASTUZUMAB DERUXTECANPHASE2ClinicalTrials.gov
NCT07123441IRINOTECANPHASE2ClinicalTrials.gov
NCT07117864TRASTUZUMAB DERUXTECANClinicalTrials.gov
NCT07114861IRINOTECANPHASE1/PHASE2ClinicalTrials.gov
NCT07114666IRINOTECANClinicalTrials.gov
NCT07108595TRASTUZUMAB DERUXTECANClinicalTrials.gov
NCT07106528TOPOTECANPHASE2/PHASE3ClinicalTrials.gov
NCT07106034IRINOTECANPHASE2ClinicalTrials.gov

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7150/trials?page=7